KLR Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$695K Sell
5,475
-61
-1% -$7.52K 0.5% 50
2023
Q4
$608K Buy
5,536
+280
+5% +$29.1K 0.44% 55
2023
Q3
$563K Sell
5,256
-452
-8% -$48.7K 0.51% 50
2023
Q2
$663K Buy
5,708
+174
+3% +$19.8K 0.55% 43
2023
Q1
$593K Sell
5,534
-1,073
-16% -$116K 0.52% 47
2022
Q4
$738K Buy
+6,607
New +$675K 0.61% 36

Other funds holding MRK

KLR Investment Advisors's MRK Position: Q1 2024 in Review

KLR Investment Advisors reduced its Merck (MRK) stake by 1.1% in Q1 2024, selling an estimated $7.52K and leaving 5,475 shares worth $695K. The position accounts for 0.5% of the portfolio, ranked #50.

KLR Investment Advisors first reported a position in MRK in Q4 2022 and has held it in 6 quarters since. The position peaked at $738K in Q4 2022. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • KLR Investment Advisors held 5,475 shares of Merck worth $695K as of Q1 2024.
  • KLR Investment Advisors sold 61 Merck shares in Q1 2024, an estimated $7.52K.
  • Merck made up 0.5% of KLR Investment Advisors's portfolio in Q1 2024, its #50 holding.
  • KLR Investment Advisors first reported a position in Merck in Q4 2022 and has held it in 6 quarters since.
  • KLR Investment Advisors's Merck position peaked at $738K in Q4 2022.
  • 3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on KLR Investment Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.